| # | Drug | Count |
|---|---|---|
| 0 | MYCOPHENOLATE MOFETIL | 125 |
| 1 | PREDNISOLONE | 94 |
| 2 | PREDNISOLONE ORAL | 94 |
| 3 | PREDNISOLONE ORAL SOLUTION | 94 |
| 4 | PREDNISONE | 88 |
| 5 | TACROLIMUS | 82 |
| 6 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 81 |
| 7 | TACROLIMUS OINTMENT 0.1% | 81 |
| 8 | METHYLPREDNISOLONE | 60 |
| 9 | METHOTREXATE SODIUM | 59 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SUTIMLIMAB-JOME | 4 | 0.0125 |
| 1 | PEGLOTICASE | 8 | 0.0021 |
| 2 | RIFABUTIN | 5 | 0.0018 |
| 3 | EPCORITAMAB-BYSP | 2 | 0.0015 |
| 4 | BELATACEPT | 7 | 0.0015 |
| 5 | NELARABINE | 1 | 0.0010 |
| 6 | VALGANCICLOVIR | 19 | 0.0010 |
| 7 | MYCOPHENOLATE MOFETIL | 125 | 0.0009 |
| 8 | ELRANATAMAB-BCMM | 1 | 0.0009 |
| 9 | THIOTEPA | 8 | 0.0008 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Classical Complement Pathway Inhibitor [EPC] | 4 | 0.0125 |
| 1 | CD38-directed Cytolytic Antibody [EPC] | 21 | 0.0036 |
| 2 | Uric Acid-specific Enzyme [EPC] | 8 | 0.0021 |
| 3 | Selective T Cell Costimulation Blocker [EPC] | 7 | 0.0015 |
| 4 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 5 | Rifamycin Antimycobacterial [EPC] | 5 | 0.0014 |
| 6 | Type I Interferon Receptor Antagonist [EPC] | 2 | 0.0010 |
| 7 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 22 | 0.0010 |
| 8 | Antimetabolite Immunosuppressant [EPC] | 11 | 0.0005 |
| 9 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 2 | 0.0005 |